1. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Lond Engl. 2016;388:1603–58.
2. Lee I-M, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet Lond Engl. 2012;380:219–29.
3. NCD Countdown 2030 collaborators. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet Lond Engl. 2018;392:1072–88.
4. World Health Organization. World Health Statistics 2018: Monitoring health for the SDGs. 2018.
5. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, et al. Global health 2035: a world converging within a generation. Lancet Lond Engl. 2013;382:1898–955.
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet Lond Engl. 2005;365:217–23.
7. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet Lond Engl. 2013;382:1575–86.
8. Afshin A, Micha R, Webb M, Capewell S, Whitsel L, Rubinstein A, et al. Effectiveness of Dietary Policies to Reduce Noncommunicable Diseases. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya J-C, Wu Y, Nugent R, editors. Cardiovascular, Respiratory, and Related Disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017. http://www.ncbi.nlm.nih.gov/books/NBK525147/. Accessed 10 Sep 2019.
9. Juma PA, Mohamed SF, Matanje Mwagomba BL, Ndinda C, Mapa-Tassou C, Oluwasanu M, et al. Non-communicable disease prevention policy process in five African countries. BMC Public Health. 2018;18 Suppl 1:961.
10. Shield K, Manthey J, Rylett M, Probst C, Wettlaufer A, Parry CDH, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health. 2020;5:e51–61.
11. Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. The Lancet. 2019;393:2493–502.
12. World Health Organization. Global Status Report on Alcohol and Health—2014. 2014.
13. Shield KD, Rylett M, Gmel G, Gmel G, Kehoe-Chan TAK, Rehm J. Global alcohol exposure estimates by country, territory and region for 2005--a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addict Abingdon Engl. 2013;108:912–22.
14. Clausen T, Rossow I, Naidoo N, Kowal P. Diverse alcohol drinking patterns in 20 African countries. Addict Abingdon Engl. 2009;104:1147–54.
15. Reuters. SABMiller Eyes Africa $2.5bn Investment. 2012. http://www.iol.co.za/business/international/sabmiller-eyes-africa-25bn-investment-1277086. Accessed 8 Jul 2019.
16. African Business. Alcohol Consumption Rising in Africa Despite Obstacles. https://africanbusinessmagazine.com/sectors/retail/alcohol-consumption-rising-in-africa-despite-obstacles/. Accessed 8 Jul 2019.
17. Chaiyasong S, Huckle T, Mackintosh A-M, Meier P, Parry CDH, Callinan S, et al. Drinking patterns vary by gender, age and country-level income: Cross-country analysis of the International Alcohol Control Study. Drug Alcohol Rev. 2018;37 Suppl 2:S53–62.
18. Huckle T, Romeo JS, Wall M, Callinan S, Holmes J, Meier P, et al. Socio-economic disadvantage is associated with heavier drinking in high but not middle-income countries participating in the International Alcohol Control Study. Drug Alcohol Rev. 2018;37 Suppl 2:S63–71.
19. Martinez P, Røislien J, Naidoo N, Clausen T. Alcohol abstinence and drinking among African women: data from the World Health Surveys. BMC Public Health. 2011;11:160.
20. Popova S, Lange S, Probst C, Shield K, Kraicer-Melamed H, Ferreira-Borges C, et al. Actual and predicted prevalence of alcohol consumption during pregnancy in the WHO African Region. Trop Med Int Health TM IH. 2016;21:1209–39.
21. Sanou AS, Diallo AH, Holding P, Nankabirwa V, Engebretsen IMS, Ndeezi G, et al. Maternal alcohol consumption during pregnancy and child’s cognitive performance at 6-8 years of age in rural Burkina Faso: an observational study. PeerJ. 2017;5:e3507.
22. Mosdøl A, Lidal IB, Straumann GH, Vist GE. Targeted mass media interventions promoting healthy behaviours to reduce risk of non-communicable diseases in adult, ethnic minorities. Cochrane Database Syst Rev. 2017;2:CD011683.
23. Soubeiga JK, Millogo T, Bicaba BW, Doulougou B, Kouanda S. Prevalence and factors associated with hypertension in Burkina Faso: a countrywide cross-sectional study. BMC Public Health. 2017;17:64.
24. Bonnechère B, Cissé K, Millogo Tiéba, Ouédraogo H. Gautier, Garanet Franck, Ouedraogo Adja Mariam, et al. Tobacco use and associated risk factors in Burkina Faso: Results from a nationwide population-based survey. BMC Public Health. 2019.
25. Institut National de la Statistique et de la Démographie (INSD); ICF International. Enquête Démographique et de Santé et à Indicateurs Multiples du Burkina Faso 2010. 2012.
26. Ministère de la santé du Burkina Faso. Rapport de l’enquête nationale sur la prévalence des principaux facteurs de risque communs aux maladies non transmissibles (STEPS 2013). 2014.
27. Bonnet E, Lechat L, Ridde V. What interventions are required to reduce road traffic injuries in Africa? A scoping review of the literature. PloS One. 2018;13:e0208195.
28. WHO. STEPwise approach to chronic disease risk factor surveillance. https://www.who.int/ncds/surveillance/steps/burkina_faso/en/.
29. Millogo T, Bicaba BW, Soubeiga JK, Dabiré E, Médah I, Kouanda S. Diabetes and abnormal glucose regulation in the adult population of Burkina Faso: prevalence and predictors. BMC Public Health. 2018;18. doi:10.1186/s12889-018-5257-4.
30. Kendagor A, Gathecha G, Ntakuka MW, Nyakundi P, Gathere S, Kiptui D, et al. Prevalence and determinants of heavy episodic drinking among adults in Kenya: analysis of the STEPwise survey, 2015. BMC Public Health. 2018;18:1216.
31. Jemmott JB, Ditto PH, Croyle RT. Judging health status: effects of perceived prevalence and personal relevance. J Pers Soc Psychol. 1986;50:899–905.
32. Dixon MA, Chartier KG. Alcohol Use Patterns Among Urban and Rural Residents: Demographic and Social Influences. Alcohol Res Curr Rev. 2016;38:69–77.
33. Meda N, Tuaillon E, Kania D, Tiendrebeogo A, Pisoni A, Zida S, et al. Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study. Bull World Health Organ. 2018;96:750–9.
34. Takahashi R, Wilunda C, Magutah K, Mwaura-Tenambergen W, Wilunda B, Perngparn U. Correlates of alcohol consumption in rural western Kenya: A cross-sectional study. BMC Psychiatry. 2017;17:175.
35. Erol A, Karpyak VM. Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations. Drug Alcohol Depend. 2015;156:1–13.
36. Kuntsche E, Kuntsche S, Thrul J, Gmel G. Binge drinking: Health impact, prevalence, correlates and interventions. Psychol Health. 2017;32:976–1017.
37. Livingston M, Raninen J, Slade T, Swift W, Lloyd B, Dietze P. Understanding trends in Australian alcohol consumption-an age-period-cohort model. Addict Abingdon Engl. 2016;111:1590–8.
38. Heffernan M, Mather KA, Xu J, Assareh AA, Kochan NA, Reppermund S, et al. Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study. J Alzheimers Dis JAD. 2016;52:529–38.
39. Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, et al. Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:31–42.
40. Gutwinski S, Schreiter S, Priller J, Henssler J, Wiers CE, Heinz A. Drink and Think: Impact of Alcohol on Cognitive Functions and Dementia - Evidence of Dose-Related Effects. Pharmacopsychiatry. 2018;51:136–43.
41. O’Keefe JH, Bhatti SK, Bajwa A, DiNicolantonio JJ, Lavie CJ. Alcohol and cardiovascular health: the dose makes the poison…or the remedy. Mayo Clin Proc. 2014;89:382–93.
42. Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol. 2015;12:576–87.
43. Rehm J, Roerecke M. Cardiovascular effects of alcohol consumption. Trends Cardiovasc Med. 2017;27:534–8.
44. Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA. Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis. Circulation. 2016;133:979–87.
45. Cyril S, Smith BJ, Renzaho AMN. Systematic review of empowerment measures in health promotion. Health Promot Int. 2016;31:809–26.
46. Gelius P, Rütten A. Conceptualizing structural change in health promotion: why we still need to know more about theory. Health Promot Int. 2018;33:657–64.
47. Roerecke M. On bias in alcohol epidemiology and the search for the perfect study. Addict Abingdon Engl. 2017;112:217–8.
48. Cook WK, Bond J, Greenfield TK. Are alcohol policies associated with alcohol consumption in low- and middle-income countries? Addict Abingdon Engl. 2014;109:1081–90.